Mitsui Crecimiento futuro

Future controles de criterios 0/6

Se prevé que los ingresos y los beneficios de Mitsui disminuyan a un ritmo anual de 0.7% y 4.7% respectivamente. Se espera que el BPA disminuya en un 2.5% al año. Se prevé que la rentabilidad financiera sea de 10.6% en 3 años.

Información clave

-4.7%

Tasa de crecimiento de los beneficios

-2.5%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Trade Distributors	1.6%
Tasa de crecimiento de los ingresos	-0.7%
Rentabilidad financiera futura	10.6%
Cobertura de analistas	Good
Última actualización	16 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Previsiones de crecimiento de beneficios e ingresos

TSE:8031 - Estimaciones futuras de los analistas y datos financieros pasados (JPY Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
3/31/2027	12,856,300	877,500	359,000	809,000	1
3/31/2026	13,074,790	902,430	676,670	1,041,529	8
3/31/2025	12,841,475	891,797	603,435	1,065,830	9
3/31/2024	13,069,194	973,248	685,758	1,024,491	8
12/31/2023	13,268,359	1,016,250	854,366	1,129,245	N/A
9/30/2023	13,260,025	1,047,787	943,039	1,203,663	N/A
6/30/2023	13,735,002	1,108,480	896,454	1,133,430	N/A
3/31/2023	14,306,402	1,130,630	819,472	1,047,537	N/A
12/31/2022	14,204,645	1,122,253	828,221	1,047,769	N/A
9/30/2022	13,765,175	1,049,196	606,857	810,110	N/A
6/30/2022	12,820,056	998,458	715,267	908,526	N/A
3/31/2022	11,757,559	914,722	621,371	806,896	N/A
12/31/2021	10,859,096	769,777	448,904	629,269	N/A
9/30/2021	9,721,360	630,064	520,042	699,016	N/A
6/30/2021	8,822,896	464,165	607,883	787,963	N/A
3/31/2021	8,010,235	335,458	557,006	772,696	N/A
12/31/2020	9,030,709	255,374	389,170	641,955	N/A
9/30/2020	8,777,968	267,384	289,611	580,535	N/A
6/30/2020	8,696,383	329,034	254,470	562,537	N/A
3/31/2020	8,484,130	391,513	238,537	526,376	N/A
12/31/2019	7,138,544	399,223	149,575	436,068	N/A
9/30/2019	7,155,418	425,498	284,193	575,690	N/A
6/30/2019	7,034,445	420,837	102,170	403,934	N/A
3/31/2019	6,957,524	414,215	102,951	410,670	N/A
12/31/2018	6,252,108	391,713	233,276	512,138	N/A
9/30/2018	5,711,458	403,042	326,549	553,773	N/A
6/30/2018	5,266,688	426,137	282,735	485,498	N/A
3/31/2018	4,892,149	418,479	379,491	553,645	N/A
12/31/2017	4,841,203	452,637	407,338	586,104	N/A
9/30/2017	4,725,866	422,466	N/A	492,570	N/A
6/30/2017	4,525,658	355,747	N/A	567,464	N/A
3/31/2017	4,363,969	306,136	N/A	404,171	N/A
12/31/2016	4,261,355	12,485	N/A	406,177	N/A
9/30/2016	4,293,998	-92,074	N/A	334,578	N/A
6/30/2016	4,495,976	-119,202	N/A	452,353	N/A
3/31/2016	4,759,694	-83,410	N/A	586,991	N/A
12/31/2015	4,912,066	186,513	N/A	572,788	N/A
9/30/2015	5,155,193	214,471	N/A	591,822	N/A
6/30/2015	5,318,093	275,621	N/A	683,952	N/A
3/31/2015	5,404,930	306,490	N/A	639,967	N/A
12/31/2014	5,574,755	287,616	N/A	552,354	N/A
9/30/2014	5,615,020	369,063	N/A	583,650	N/A
6/30/2014	5,695,151	344,931	N/A	496,615	N/A
3/31/2014	5,731,918	350,093	N/A	449,243	N/A
12/31/2013	5,659,799	359,606	N/A	457,526	N/A
9/30/2013	5,410,687	331,976	N/A	467,519	N/A
6/30/2013	5,139,632	325,144	N/A	404,048	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que los beneficios de 8031 disminuyan en los próximos 3 años (-4.7% al año).

Beneficios vs. Mercado: Se prevé que los beneficios de 8031 disminuyan en los próximos 3 años (-4.7% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de 8031 disminuyan en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos de 8031 disminuyan en los próximos 3 años (-0.7% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos de 8031 disminuyan en los próximos 3 años (-0.7% al año).

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de 8031 sea baja dentro de 3 años (10.7%).

Descubre empresas en crecimiento

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Mitsui Crecimiento futuro

Future controles de criterios 0/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Mitsui & Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2024

Mitsui & Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2024

Mitsui & Co., Ltd. Revises Consolidated Earnings Guidance for the Year Ending March 31, 2023

Price target increased to JP¥4,418

Recent updates

Rohto Pharmaceutical Co.,Ltd. (TSE:4527), Mitsui & Co., Ltd. (TSE:8031) and others agreed to acquire an 86% stake in Eu Yan Sang International Ltd from Blanca Investments Pte. Ltd., Tower Capital Asia and founding family for approximately SGD 690 million.

Mitsui (TSE:8031) Is Due To Pay A Dividend Of ¥85.00

Mitsui & Co., Ltd. to Report Fiscal Year 2024 Results on May 01, 2024

Upcoming dividend of JP¥85.00 per share

Mitsui & Co., Ltd.'s (TSE:8031) Prospects Need A Boost To Lift Shares

Mitsui's (TSE:8031) Dividend Will Be ¥85.00

Mitsui & Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2024

Third quarter 2024 earnings: Revenues exceed analyst expectations

Mitsui & Co., Ltd. Announces Change of Director

Mitsui & Co., Ltd., Annual General Meeting, Jun 19, 2024

Mitsui & Co., Ltd. to Report Q3, 2024 Results on Feb 02, 2024

RGF Staffing B.V. entered into share sale and purchase agreement to acquire additional 30% stake in RGF Staffing Delaware, Inc. from Mitsui & Co., Ltd. (TSE:8031) for approximately 130 million.

Mitsui & Co., Ltd. (TSE:8031) announces an Equity Buyback for 12,500,000 shares, representing 0.83% for ¥50,000 million.

Second quarter 2024 earnings: EPS misses analyst expectations

BEMAC Corporation and Mitsui & Co., Ltd. entered into a share purchase agreement to acquire 100% of the shares of The Switch Engineering Oy from YASKAWA Electric Corporation.

Mitsui & Co., Ltd. to Report First Half, 2024 Results on Oct 31, 2023

Upcoming dividend of JP¥75.00 per share at 2.6% yield

Mitsui & Co., Ltd. (TSE:8031) completed the acquisition of 49% stake in Solar Park Kassø Aps from European Energy A/S.

Mitsui & Co., Ltd. (TSE:8031) acquired 33.3% stake in Terreva Renewables, LLC from CIM Group, L.P.

CPC Reportedly Set for Dorado Stake

Mitsui & Co., Ltd. (TSE:8031) agreed to acquire Dermaceutical Laboratories Limited Liability Company.

Mitsui & Co., Ltd. to Report Q1, 2024 Final Results on Aug 09, 2023

Beacon Rail Metro Finance B.V. signed a share purchase agreement to acquire Mitsui Rail Capital Europe B.V. from Mitsui & Co., Ltd. (TSE:8031).

Yangzijiang Shipbuilding (Holdings) Ltd. (SGX:BS6) acquired additional 5% stake in Jiangsu Yangzi-Mitsui Shipbuilding Co. Ltd. from Mitsui & Co., Ltd. (TSE:8031) and Mitsui E&S Shipbuilding Co., Ltd for CNY 43.2 million.

Mitsui & Co., Ltd. Provides Consolidated Earnings Guidance for the Full Year Ending March 31, 2024

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Mitsui & Co., Ltd. (TSE:8031) executed a share purchase agreement to acquire STATS (UK) Ltd from BGF Investment Management Ltd. and others.

Mitsui & Co., Ltd. to Report Q1, 2024 Results on Aug 01, 2023

Mitsui & Co., Ltd. (TSE:8031) entered into binding agreements to acquire minority shareholder in EURICOM S.p.a. for enterprise value approximately €500 million.

Mitsui, Osaka Gas Reportedly Bid for ReNew Energy's Commercial and Industrial Project Portfolio

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Upcoming dividend of JP¥70.00 per share at 3.4% yield

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Mitsui & Co., Ltd. (TSE:8031) agreed to acquire remaining 50% stake in Aim Services Co., Ltd. from Aramark (NYSE:ARMK) for ¥70 billion.

Mitsui & Co., Ltd. Revises Consolidated Earnings Guidance for the Year Ending March 31, 2023

Mitsui & Co., Ltd. Announces Management Changes

Mitsui & Co., Ltd. (TSE:8031) agreed to acquire Sumitomo Pharma Animal Health Co., Ltd. from Sumitomo Pharma Co., Ltd. (TSE:4506).

Mitsui & Co., Ltd. to Report Nine Months, 2023 Results on Feb 03, 2023

Price target increased to JP¥4,418

CFW Partners, L.P, Mitsui & Co., Ltd. (TSE:8031), Fuyo General Lease Co., Ltd. (TSE:8424) and JA Mitsui Leasing, Ltd. submitted a non-binding proposal to acquire remaining 2.1% stake in Willis Lease Finance Corporation (NasdaqGM:WLFC) for $29.3 million.

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

ACTIS GP LLP completed the acquisition of 40% share in MT Falcon Holdings Company S.A.P.I. de C.V. from Mitsui & Co., Ltd.

Woodside Reportedly Weighs Up Options for Scarborough

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento